Golden Road Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Buy
1,801
+77
+4% +$17.9K 0.22% 40
2026
Q1
$421K Buy
1,724
+225
+15% +$52.4K 0.24% 36
2025
Q4
$310K Sell
1,499
-172
-10% -$34K 0.18% 37
2025
Q3
$310K Buy
+1,671
New +$286K 0.18% 40
2024
Q4
Sell
-1,320
Closed -$214K 40
2024
Q3
$214K Buy
+1,320
New +$210K 0.17% 38
2024
Q2
Sell
-1,526
Closed -$241K 38
2024
Q1
$241K Buy
1,526
+9
+0.6% +$1.43K 0.2% 34
2023
Q4
$238K Buy
+1,517
New +$233K 0.23% 30

Other funds holding JNJ

Golden Road Advisors's JNJ Position: Q2 2026 in Review

Golden Road Advisors increased its Johnson & Johnson (JNJ) stake by 4.5% in Q2 2026, buying an estimated $17.9K and bringing the position to 1,801 shares worth $457K. The position accounts for 0.22% of the portfolio, ranked #40.

Golden Road Advisors first reported a position in JNJ in Q4 2023 and has held it in 7 quarters since. 4,651 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Golden Road Advisors held 1,801 shares of Johnson & Johnson worth $457K as of Q2 2026.
  • Golden Road Advisors bought 77 Johnson & Johnson shares in Q2 2026, an estimated $17.9K.
  • Johnson & Johnson made up 0.22% of Golden Road Advisors's portfolio in Q2 2026, its #40 holding.
  • Golden Road Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 7 quarters since.
  • 4,651 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Golden Road Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.